Literature DB >> 23886640

Systemic lupus erythematosus complicating autoimmune pulmonary alveolar proteinosis that was worsened by immunosuppressive therapy.

J Nagasawa1, K Kurasawa, R Maezawa, T Owada, R Hanaoka, T Fukuda.   

Abstract

A 26-year-old Japanese woman developed autoimmune pulmonary alveolar proteinosis (PAP) during glucocorticoid therapy for systemic lupus erythematosus (SLE). Intensive immunosuppressive therapy worsened the PAP. De-escalation of immunosuppressive therapy improved the PAP. Autoimmune PAP is rarely associated with systemic autoimmune diseases, and the present case is the first case of autoimmune PAP associated with SLE. Moreover, the present case suggests that immunosuppressive therapy should be avoided or used carefully for the treatment of patients with anti-GM-CSF antibody, such as those with autoimmune PAP.

Entities:  

Keywords:  GM-CSF; Systemic lupus erythematosus; immunosuppression; pulmonary diseases

Mesh:

Substances:

Year:  2013        PMID: 23886640     DOI: 10.1177/0961203313498798

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  2 in total

1.  Longitudinal lung involvement of systemic lupus erythematosus-related vasculitis and alveolar proteinosis-like reaction.

Authors:  Takahito Suzuki; Noriyuki Enomoto; Yasuoki Horiike; Kazuhiro Asada; Toshihiro Shirai; Takafumi Suda
Journal:  Respirol Case Rep       Date:  2020-04-17

2.  Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report.

Authors:  S Sato; K Akasaka; H Ohta; Y Tsukahara; G Kida; E Tsumiyama; K Kusano; T Oba; T Nishizawa; R Kawabe; H Yamakawa; M Amano; H Matsushima; T Takada
Journal:  BMC Pulm Med       Date:  2020-04-06       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.